Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
MASP2	10747	broad.mit.edu	37	1	11087589	11087589	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	g.chr1:11087589G>A	ENST00000400897.3	-	11	1429	c.1414C>T	c.(1414-1416)Ctt>Ttt	p.L472F	RP4-635E18.8_ENST00000607145.1_RNA	NM_006610.3	NP_006601.2	O00187	MASP2_HUMAN	mannan-binding lectin serine peptidase 2	472	Peptidase S1.	NA			complement activation, classical pathway|complement activation, lectin pathway|proteolysis	extracellular region	calcium ion binding|calcium-dependent protein binding|serine-type endopeptidase activity			biliary_tract(1)|endometrium(2)|large_intestine(6)|lung(5)|ovary(2)|pancreas(1)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(2)	23	Ovarian(185;0.249)	Lung NSC(185;1.04e-05)|all_lung(284;1.31e-05)|Renal(390;0.000147)|Colorectal(325;0.00205)|Breast(348;0.00262)|Hepatocellular(190;0.00913)|Ovarian(437;0.00965)|Myeloproliferative disorder(586;0.0255)	STAD - Stomach adenocarcinoma(5;0.071)	UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;3.12e-07)|COAD - Colon adenocarcinoma(227;7.07e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|Kidney(185;0.000722)|KIRC - Kidney renal clear cell carcinoma(229;0.00258)|READ - Rectum adenocarcinoma(331;0.0487)|STAD - Stomach adenocarcinoma(313;0.192)		TCATATAAAAGTGCACCTGCT	0.493		NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		GBM(35;611 746 20780 22741 36496)					NA		NA				0											NA		133	130	131	NA		NA	NA	1		NA											NA				11087589		2203	4300	6503	SO:0001583	missense			ENSG00000009724	HGNC:6902	NM_006610	Approved	uc001aru.3	NA	A8K458|A8MWJ2|O75754|Q5TEQ5|Q5TER0|Q96QG4|Q9BZH0|Q9H498|Q9H499|Q9UBP3|Q9UC48|Q9ULC7|Q9UMV3|Q9Y270	ENST00000400897.3	37	CCDS123.1	.	.	.	.	.	.	.	.	.	.	G	21.2	4.108251	0.77096	.	.	ENSG00000009724	ENST00000400897	D	0.97404	-4.37	5.45	5.45	0.79879	Peptidase cysteine/serine, trypsin-like (1);Peptidase S1/S6, chymotrypsin/Hap (3);	0.000000	0.64402	D	0.000001	D	0.98865	0.9616	M	0.94142	3.5	0.80722	D	1	D	0.89917	1.0	D	0.91635	0.999	D	0.99601	1.0978	10	0.87932	D	0	.	15.6353	0.76946	0.0:0.0:0.8622:0.1378	.	472	O00187	MASP2_HUMAN	F	472	ENSP00000383690:L472F	ENSP00000383690:L472F	L	-	1	0	MASP2	11010176	1	0.71417	0.362	0.25862	0.982	0.71751	3.883	0.56168	2.549	0.85964	0.563	0.77884	CTT	MASP2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000006072.1	184.09223	KEEP		-	184.831377	0.422535	60	82	---	---	---	---	1	0.9873684	3	8	0	177	69	89	0	177	2	0	0	0	0	0	0	69	89	0	177	2	TP
RNF2	6045	broad.mit.edu	37	1	185069006	185069006	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	g.chr1:185069006G>A	ENST00000367510.3	+	6	1109	c.821G>A	c.(820-822)aGc>aAc	p.S274N	RNF2_ENST00000367509.4_Missense_Mutation_p.S202N	NM_007212.3	NP_009143.1	Q99496	RING2_HUMAN	ring finger protein 2	274		NA			histone H2A monoubiquitination|transcription, DNA-dependent	MLL1 complex|PcG protein complex|ubiquitin ligase complex	RING-like zinc finger domain binding|zinc ion binding			breast(3)|endometrium(2)|large_intestine(4)|lung(3)|skin(2)	14		Breast(1374;0.000496)		Colorectal(1306;6.9e-08)|KIRC - Kidney renal clear cell carcinoma(1967;8.12e-06)		GAACTTCGAAGCAAAGGTGAA	0.393		NA						NA					G	1	5e-04	NA	NA	2184	0.0017	1	,	,	NA	3e-04	NA	NA	NA	5e-04	1	EXOME	NA	NA	6e-04	SNP						NA		NA				0											NA		96	96	96	NA		NA	NA	1		NA											NA				185069006		2203	4300	6503	SO:0001583	missense			ENSG00000121481	HGNC:10061	NM_007212	Approved	uc001grc.1	NA	B2RBS7|Q5TEN1|Q5TEN2	ENST00000367510.3	37	CCDS1365.1	1	4.578754578754579E-4	0	0.0	0	0.0	1	0.0017482517482517483	0	0.0	G	14.86	2.660886	0.47572	.	.	ENSG00000121481	ENST00000367510;ENST00000367509	D	0.85171	-1.95	5.83	3.95	0.45737	.	0.108653	0.85682	N	0.000000	T	0.74711	0.3752	N	0.22421	0.69	0.4305	D	0.994659	B;B	0.14012	0.009;0.0	B;B	0.04013	0.001;0.0	T	0.67217	-0.5726	10	0.36615	T	0.2	-31.6795	11.35	0.49583	0.0654:0.0:0.808:0.1267	.	202;274	B3KRH1;Q99496	.;RING2_HUMAN	N	274;202	ENSP00000356480:S274N	ENSP00000356479:S202N	S	+	2	0	RNF2	183335629	1	0.71417	1	0.80357	0.99	0.78478	5.015	0.64035	0.809	0.34255	-0.187	0.12897	AGC	RNF2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000085793.1	-24.319556	KEEP		+	7.917221	0.030075	4	129	---	---	---	---	1	0.8977862	6	111	0	143	5	140	0	143	2	0	0	0	0	0	0	5	140	0	143	2	TP
PIGF	5281	broad.mit.edu	37	2	46808672	46808672	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	g.chr2:46808672A>G	ENST00000281382.6	-	6	775	c.605T>C	c.(604-606)aTt>aCt	p.I202T	RHOQ_ENST00000238738.4_3'UTR|RP11-417F21.1_ENST00000506009.2_RNA|PIGF_ENST00000306465.4_3'UTR	NM_002643.3	NP_002634.1	Q07326	PIGF_HUMAN	phosphatidylinositol glycan anchor biosynthesis, class F	202		NA			C-terminal protein lipidation|preassembly of GPI anchor in ER membrane	endoplasmic reticulum membrane|integral to membrane	ethanolaminephosphotransferase activity			breast(1)|endometrium(1)|lung(1)|stomach(1)	4		all_hematologic(82;0.151)|Acute lymphoblastic leukemia(82;0.175)	LUSC - Lung squamous cell carcinoma(58;0.114)			GAGTGGTGAAATAACAAGGCC	0.418		NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0											NA		42	41	41	NA		NA	NA	2		NA											NA				46808672		2203	4299	6502	SO:0001583	missense			ENSG00000151665	HGNC:8962	NM_173074	Approved	uc002rvd.3	NA	Q8WW20	ENST00000281382.6	37	CCDS1827.1	.	.	.	.	.	.	.	.	.	.	A	10.24	1.295085	0.23564	.	.	ENSG00000151665	ENST00000281382	.	.	.	5.54	1.84	0.25277	.	0.258782	0.45361	N	0.000376	T	0.43964	0.1271	M	0.62266	1.93	0.0931	N	0.999999	B	0.27910	0.193	B	0.31390	0.129	T	0.39396	-0.9616	9	0.49607	T	0.09	-2.1903	9.73	0.40355	0.8028:0.0:0.1972:0.0	.	202	Q07326	PIGF_HUMAN	T	202	.	ENSP00000281382:I202T	I	-	2	0	PIGF	46662176	0.984	0.35163	0.036	0.18154	0.992	0.81027	3.473	0.53122	0.166	0.19597	-0.297	0.09499	ATT	PIGF-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250749.2	34.84392	KEEP		-	35.34653	0.357143	10	18	---	---	---	---	1	1	155	508	0	41	12	21	0	41	2	0	0	0	0	0	0	12	21	0	41	2	TP
EVA1A	84141	broad.mit.edu	37	2	75720689	75720689	+	Silent	SNP	G	G	A			GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	g.chr2:75720689G>A	ENST00000233712.1	-	4	569	c.132C>T	c.(130-132)atC>atT	p.I44I	EVA1A_ENST00000393913.3_Silent_p.I44I|EVA1A_ENST00000490746.1_Intron|EVA1A_ENST00000410113.1_Silent_p.I44I|EVA1A_ENST00000410010.1_Silent_p.I32I|EVA1A_ENST00000410071.1_Silent_p.I44I	NM_032181.2	NP_115557.1			eva-1 homolog A (C. elegans)	NA		NA									NA						GCACCAGCCCGATGCACACGC	0.537		NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0											NA		34	32	33	NA		NA	NA	2		NA											NA				75720689		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000115363	HGNC:25816	NM_032181	Approved		NA		ENST00000233712.1	37	CCDS1959.1												NA	NA	NA								NA	NA	NA												NA		NA															NA	NA												NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		EVA1A-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000328707.1	29.404893	KEEP		-	31.559717	0.261905	11	31	---	---	---	---	1	0.8147386	5	6	0	32	11	31	0	32	2	0	0	0	0	0	0	11	31	0	32	2	TP
ABI2	10152	broad.mit.edu	37	2	204260428	204260428	+	Nonsense_Mutation	SNP	C	C	T			GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	g.chr2:204260428C>T	ENST00000295851.4	+	7	1071	c.775C>T	c.(775-777)Cga>Tga	p.R259*	ABI2_ENST00000424558.1_Nonsense_Mutation_p.R253*|ABI2_ENST00000430574.1_3'UTR|ABI2_ENST00000261016.6_Nonsense_Mutation_p.R208*|ABI2_ENST00000261017.5_Nonsense_Mutation_p.R253*|ABI2_ENST00000430418.1_Nonsense_Mutation_p.R204*|ABI2_ENST00000422511.2_Nonsense_Mutation_p.R259*|RAPH1_ENST00000457812.1_Intron|ABI2_ENST00000261018.7_Nonsense_Mutation_p.R45*			Q9NYB9	ABI2_HUMAN	abl-interactor 2	259	Pro-rich.	NA			actin polymerization or depolymerization|cell migration|peptidyl-tyrosine phosphorylation	cytoskeleton|cytosol|filopodium|lamellipodium	cytoskeletal adaptor activity|DNA binding|kinase binding|proline-rich region binding|SH3 domain binding|ubiquitin protein ligase binding			breast(1)|kidney(3)|large_intestine(1)|liver(2)|lung(4)|prostate(2)|skin(1)|urinary_tract(1)	15						GAGCAGCAGTCGAGAGAACAG	0.478		NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0											NA		214	182	193	NA		NA	NA	2		NA											NA				204260428		2203	4300	6503	SO:0001587	stop_gained			ENSG00000138443	HGNC:24011	NM_005759	Approved	uc002uzz.3	NA	B4DSN1|Q13147|Q13249|Q13801|Q9BV70	ENST00000295851.4	37		.	.	.	.	.	.	.	.	.	.	C	38	7.163097	0.98107	.	.	ENSG00000138443	ENST00000295851;ENST00000261017;ENST00000430418;ENST00000424558;ENST00000261016;ENST00000417864;ENST00000422511;ENST00000261018	.	.	.	5.81	4.93	0.64822	.	0.101668	0.64402	D	0.000002	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	0.02654	T	1	-4.5701	16.3042	0.82842	0.1335:0.8665:0.0:0.0	.	.	.	.	X	259;253;204;253;208;259;259;45	.	ENSP00000261016:R208X	R	+	1	2	ABI2	203968673	0.999	0.42202	0.995	0.50966	0.994	0.84299	1.713	0.37951	1.451	0.47736	0.65	0.86243	CGA	ABI2-001	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000256367.5	106.313083	KEEP		+	110.032428	0.31405	38	83	---	---	---	---	1	1	6	139	1	153	45	89	1	153	6	0	0	0	0	0	0	45	89	1	153	2	TP
RAF1	5894	broad.mit.edu	37	3	12632402	12632402	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	g.chr3:12632402T>C	ENST00000251849.4	-	12	1704	c.1265A>G	c.(1264-1266)cAg>cGg	p.Q422R	RAF1_ENST00000442415.2_Missense_Mutation_p.Q442R|RAF1_ENST00000534997.1_Missense_Mutation_p.Q207R|RAF1_ENST00000542177.1_Missense_Mutation_p.Q341R	NM_002880.3	NP_002871.1	P04049	RAF1_HUMAN	v-raf-1 murine leukemia viral oncogene homolog 1	422	Protein kinase.	NA			activation of MAPKK activity|apoptosis|axon guidance|cell proliferation|epidermal growth factor receptor signaling pathway|insulin receptor signaling pathway|negative regulation of apoptosis|negative regulation of cell proliferation|negative regulation of protein complex assembly|nerve growth factor receptor signaling pathway|platelet activation|positive regulation of peptidyl-serine phosphorylation|Ras protein signal transduction|synaptic transmission	cytosol|mitochondrial outer membrane|plasma membrane	ATP binding|metal ion binding|protein binding|protein serine/threonine kinase activity|receptor signaling protein activity		ESRP1/RAF1(4)|RAF1/DAZL(2)|SRGAP3/RAF1(6)	biliary_tract(1)|endometrium(4)|kidney(3)|large_intestine(9)|liver(1)|lung(7)|ovary(1)|pancreas(1)|prostate(2)|stomach(2)|upper_aerodigestive_tract(1)	32					Sorafenib(DB00398)	CTCGCACCACTGGGTCACAAT	0.542		NA	T	SRGAP3	pilocytic astrocytoma			NA	Noonan syndrome					NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		3	3p25	5894	v-raf-1 murine leukemia viral oncogene homolog 1		M	0											NA		135	125	129	NA		NA	NA	3		NA											NA				12632402		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Male Turner syndrome, Pterygium Colli syndrome, incl. Noonan-like/Multiple Giant Cell Lesion syndrome; Noonan s. with multiple lentigines/LEOPARD syndrome	ENSG00000132155	HGNC:9829	NM_002880	Approved	uc003bxf.4	NA	B0LPH8|B2R5N3|Q15278|Q9UC20	ENST00000251849.4	37	CCDS2612.1	.	.	.	.	.	.	.	.	.	.	T	25.7	4.664491	0.88251	.	.	ENSG00000132155	ENST00000251849;ENST00000442415;ENST00000432427;ENST00000534997;ENST00000542177	D;D;D;D;D	0.98914	-5.23;-5.23;-5.23;-5.23;-5.23	4.75	4.75	0.60458	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Protein kinase, catalytic domain (1);	0.000000	0.85682	D	0.000000	D	0.97907	0.9312	N	0.16368	0.405	0.80722	D	1	D;D;D	0.76494	0.999;0.994;0.994	D;D;D	0.97110	1.0;1.0;0.999	D	0.99814	1.1043	10	0.87932	D	0	.	14.7128	0.69247	0.0:0.0:0.0:1.0	.	341;207;422	B4E0X2;B4E1N6;P04049	.;.;RAF1_HUMAN	R	422;442;301;207;341	ENSP00000251849:Q422R;ENSP00000401888:Q442R;ENSP00000398591:Q301R;ENSP00000441186:Q207R;ENSP00000443567:Q341R	ENSP00000251849:Q422R	Q	-	2	0	RAF1	12607402	1	0.71417	1	0.80357	0.997	0.91878	7.82	0.86633	2.115	0.64714	0.46	0.3903	CAG	RAF1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000252015.2	-27.227784	KEEP		-	6.517644	0.028986	4	134	---	---	---	---	1	0.9970952	6	313	0	134	6	160	0	134	2	0	0	0	0	0	0	6	160	0	134	2	TP
ARL9	132946	broad.mit.edu	37	4	57389924	57389924	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	g.chr4:57389924G>A	ENST00000360096.2	+	4	568	c.254G>A	c.(253-255)gGa>gAa	p.G85E		NM_206919.1	NP_996802.1	Q6T311	ARL9_HUMAN	ADP-ribosylation factor-like 9	149		NA					GTP binding			lung(2)	2	Glioma(25;0.08)|all_neural(26;0.101)					TCTGAAGTGGGAAATGACAGG	0.433		NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0											NA		126	120	122	NA		NA	NA	4		NA											NA				57389924		1950	4152	6102	SO:0001583	missense				HGNC:23592	NM_206919	Approved	uc003hby.1	NA		ENST00000360096.2	37	CCDS59474.1	.	.	.	.	.	.	.	.	.	.	G	22.5	4.296172	0.81025	.	.	ENSG00000196503	ENST00000360096	.	.	.	5.32	5.32	0.75619	.	0.050686	0.85682	D	0.000000	T	0.73265	0.3565	L	0.47016	1.485	0.47949	D	0.99955	D	0.89917	1.0	D	0.91635	0.999	T	0.69844	-0.5035	8	0.31617	T	0.26	-20.6727	16.8642	0.86025	0.0:0.0:1.0:0.0	.	149	Q6T311	ARL9_HUMAN	E	149	.	ENSP00000353210:G149E	G	+	2	0	ARL9	57084681	1	0.71417	1	0.80357	0.988	0.76386	7.659	0.83766	2.639	0.8948	0.557	0.71058	GGA	ARL9-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000467724.1	35.322721	KEEP		+	37.990411	0.264151	14	39	---	---	---	---	1	0.9220697	7	9	0	55	14	42	0	55	2	0	0	0	0	0	0	14	42	0	55	2	TP
CARD6	84674	broad.mit.edu	37	5	40853218	40853218	+	Missense_Mutation	SNP	T	T	A			GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	g.chr5:40853218T>A	ENST00000254691.5	+	3	1983	c.1784T>A	c.(1783-1785)aTt>aAt	p.I595N	CARD6_ENST00000381677.3_Intron	NM_032587.3	NP_115976.2	Q9BX69	CARD6_HUMAN	caspase recruitment domain family, member 6	595		NA			apoptosis|regulation of apoptosis	intracellular				NS(1)|breast(2)|central_nervous_system(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(10)|liver(2)|lung(29)|ovary(2)|pancreas(1)|prostate(2)|skin(3)|urinary_tract(1)	62						GAGGCTCAAATTTTTCAGAGG	0.483		NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0											NA		117	118	118	NA		NA	NA	5		NA											NA				40853218		2203	4300	6503	SO:0001583	missense			ENSG00000132357	HGNC:16394		Approved	uc003jmg.3	NA	Q52LR2	ENST00000254691.5	37	CCDS3935.1	.	.	.	.	.	.	.	.	.	.	T	18.73	3.686618	0.68157	.	.	ENSG00000132357	ENST00000254691	T	0.13420	2.59	5.49	5.49	0.81192	.	0.437579	0.21007	N	0.081755	T	0.10895	0.0266	L	0.40543	1.245	0.80722	D	1	B	0.34372	0.451	B	0.30179	0.112	T	0.10800	-1.0614	10	0.36615	T	0.2	-6.1588	8.8455	0.35168	0.1667:0.0:0.0:0.8333	.	595	Q9BX69	CARD6_HUMAN	N	595	ENSP00000254691:I595N	ENSP00000254691:I595N	I	+	2	0	CARD6	40888975	0.22	0.23631	1	0.80357	0.949	0.60115	0.384	0.20668	2.311	0.77944	0.533	0.6212	ATT	CARD6-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000211584.3	143.279448	KEEP		+	150.707724	0.288043	53	131	---	---	---	---	0	0.8404661	0	10	0	198	60	143	0	198	2	1	1	55	133	0	202	60	143	0	198	2	TP
GABRA6	2559	broad.mit.edu	37	5	161119124	161119124	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	g.chr5:161119124C>T	ENST00000523217.1	+	8	1216	c.974C>T	c.(973-975)gCc>gTc	p.A325V	GABRA6_ENST00000274545.5_Missense_Mutation_p.A335V|RP11-348M17.2_ENST00000521984.1_RNA	NM_000811.2	NP_000802.2	Q16445	GBRA6_HUMAN	gamma-aminobutyric acid (GABA) A receptor, alpha 6	335		NA			gamma-aminobutyric acid signaling pathway	cell junction|chloride channel complex|integral to plasma membrane|postsynaptic membrane	benzodiazepine receptor activity|chloride channel activity			breast(1)|central_nervous_system(2)|endometrium(6)|large_intestine(9)|liver(2)|lung(22)|ovary(7)|skin(6)|urinary_tract(2)	57	Renal(175;0.00259)	Medulloblastoma(196;0.0208)|all_neural(177;0.0672)	Kidney(164;7.83e-05)|KIRC - Kidney renal clear cell carcinoma(164;0.000525)		Alprazolam(DB00404)|Ethchlorvynol(DB00189)|Flunitrazepam(DB01544)|Flurazepam(DB00690)|Lorazepam(DB00186)|Meprobamate(DB00371)|Midazolam(DB00683)	ACACAGAAGGCCAAAAGGAAG	0.438		NA						NA		TCGA Ovarian(5;0.080)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0											NA		162	139	147	NA		NA	NA	5		NA											NA				161119124		2203	4300	6503	SO:0001583	missense			ENSG00000145863	HGNC:4080		Approved	uc003lyu.2	NA	A8K096|Q4VAV2	ENST00000523217.1	37		.	.	.	.	.	.	.	.	.	.	C	13.04	2.119678	0.37436	.	.	ENSG00000145863	ENST00000274545;ENST00000523217	D;D	0.85556	-2.0;-2.0	5.04	3.24	0.37175	Neurotransmitter-gated ion-channel transmembrane domain (2);	4.873430	0.00839	N	0.001738	D	0.85796	0.5780	L	0.47016	1.485	0.38774	D	0.954618	B	0.20459	0.045	B	0.35353	0.201	T	0.61778	-0.6993	10	0.30854	T	0.27	.	11.6608	0.51345	0.0:0.8519:0.0:0.1481	.	335	Q16445	GBRA6_HUMAN	V	335;325	ENSP00000274545:A335V;ENSP00000430527:A325V	ENSP00000274545:A335V	A	+	2	0	GABRA6	161051702	1	0.71417	0.989	0.46669	0.678	0.3967	3.593	0.54001	1.111	0.41721	0.557	0.71058	GCC	GABRA6-003	KNOWN	not_organism_supported|basic	protein_coding	NA	protein_coding	OTTHUMT00000374125.1	53.004181	KEEP		+	57.871958	0.255556	23	67	---	---	---	---	0	0	0	0	0	123	36	74	0	123	2	1	1	17	61	0	101	36	74	0	123	2	TP
LOXL2	4017	broad.mit.edu	37	8	23225588	23225588	+	Missense_Mutation	SNP	C	C	A			GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	g.chr8:23225588C>A	ENST00000389131.3	-	2	646	c.277G>T	c.(277-279)Gcc>Tcc	p.A93S	RP11-177H13.2_ENST00000519692.1_RNA	NM_002318.2	NP_002309.1	Q9Y4K0	LOXL2_HUMAN	lysyl oxidase-like 2	93	SRCR 1.	NA			aging|cell adhesion|protein modification process	extracellular space|membrane	copper ion binding|electron carrier activity|oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor|scavenger receptor activity			breast(2)|endometrium(4)|kidney(3)|large_intestine(12)|lung(5)|ovary(2)|prostate(2)|skin(2)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	35		Prostate(55;0.0453)|Breast(100;0.143)		Colorectal(74;0.0288)|COAD - Colon adenocarcinoma(73;0.096)		ACGACGTGGGCAGCGTGGATG	0.627		NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0											NA		89	68	75	NA		NA	NA	8		NA											NA				23225588		2203	4300	6503	SO:0001583	missense				HGNC:6666		Approved	uc003xdh.1	NA	Q9BW70|Q9Y5Y8	ENST00000389131.3	37	CCDS34864.1	.	.	.	.	.	.	.	.	.	.	C	36	5.638866	0.96693	.	.	ENSG00000134013	ENST00000389131;ENST00000524144;ENST00000520871;ENST00000518083;ENST00000524168;ENST00000519243	T;T;T;T;T;T	0.74002	0.84;0.84;0.84;0.84;-0.8;-0.8	5.55	5.55	0.83447	Speract/scavenger receptor (2);Speract/scavenger receptor-related (2);	0.000000	0.85682	D	0.000000	D	0.88800	0.6535	M	0.89214	3.015	0.80722	D	1	D	0.89917	1.0	D	0.85130	0.997	D	0.90286	0.4319	10	0.87932	D	0	.	18.4111	0.9055	0.0:1.0:0.0:0.0	.	93	Q9Y4K0	LOXL2_HUMAN	S	93;174;134;93;93;93	ENSP00000373783:A93S;ENSP00000427883:A174S;ENSP00000429778:A134S;ENSP00000430519:A93S;ENSP00000428497:A93S;ENSP00000428933:A93S	ENSP00000373783:A93S	A	-	1	0	LOXL2	23281533	1	0.71417	0.954	0.39281	0.972	0.66771	7.615	0.83006	2.764	0.94973	0.563	0.77884	GCC	LOXL2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000375603.1	-16.226707	KEEP		-	10.022339	0.042735	5	112	---	---	---	---	1	0.8662124	2	57	0	85	8	125	0	85	2	0	0	0	0	0	0	8	125	0	85	2	TP
TTLL11	158135	broad.mit.edu	37	9	124751932	124751932	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	g.chr9:124751932C>T	ENST00000321582.5	-	4	1268	c.1081G>A	c.(1081-1083)Gca>Aca	p.A361T	TTLL11_ENST00000474723.1_5'UTR|TTLL11_ENST00000373776.3_Missense_Mutation_p.A361T	NM_001139442.1	NP_001132914.1	Q8NHH1	TTL11_HUMAN	tubulin tyrosine ligase-like family, member 11	361	TTL.	NA			protein modification process	cilium|microtubule basal body	tubulin-tyrosine ligase activity			breast(1)|endometrium(1)|kidney(1)|large_intestine(6)|lung(5)|prostate(3)|skin(1)	18						AGGGTCCCTGCCAGGCGGATG	0.517		NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0											NA		91	96	95	NA		NA	NA	9		NA											NA				124751932		2203	4300	6503	SO:0001583	missense			ENSG00000175764	HGNC:18113	XM_088486	Approved	uc011lyl.2	NA		ENST00000321582.5	37	CCDS48012.1	.	.	.	.	.	.	.	.	.	.	C	12.67	2.008204	0.35415	.	.	ENSG00000175764	ENST00000321582;ENST00000373776	T;T	0.05447	3.44;3.44	5.12	-3.63	0.04529	.	0.663319	0.14352	N	0.325025	T	0.02342	0.0072	N	0.11892	0.195	0.24548	N	0.994034	B;B	0.25809	0.012;0.135	B;B	0.22880	0.007;0.042	T	0.46721	-0.9171	10	0.08599	T	0.76	.	5.5755	0.1722	0.2106:0.3076:0.0:0.4819	.	361;361	F8W6M1;Q8NHH1	.;TTL11_HUMAN	T	361	ENSP00000321346:A361T;ENSP00000362881:A361T	ENSP00000321346:A361T	A	-	1	0	TTLL11	123791753	0.054	0.20591	0.984	0.44739	0.994	0.84299	-0.408	0.07169	-0.484	0.06763	-0.3	0.09419	GCA	TTLL11-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		135.61567	KEEP		-	143.431926	0.282609	52	132	---	---	---	---	1	0.9999619	8	31	0	213	60	137	0	213	2	0	0	0	0	0	0	60	137	0	213	2	TP
TTLL11	158135	broad.mit.edu	37	9	124794081	124794081	+	Missense_Mutation	SNP	T	T	A			GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	g.chr9:124794081T>A	ENST00000321582.5	-	3	1071	c.884A>T	c.(883-885)cAg>cTg	p.Q295L	TTLL11_ENST00000474723.1_Intron|TTLL11_ENST00000373776.3_Missense_Mutation_p.Q295L	NM_001139442.1	NP_001132914.1	Q8NHH1	TTL11_HUMAN	tubulin tyrosine ligase-like family, member 11	295	TTL.	NA			protein modification process	cilium|microtubule basal body	tubulin-tyrosine ligase activity			breast(1)|endometrium(1)|kidney(1)|large_intestine(6)|lung(5)|prostate(3)|skin(1)	18						AAAGAGATTCTGCATGGTTCT	0.507		NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0											NA		143	128	133	NA		NA	NA	9		NA											NA				124794081		2203	4300	6503	SO:0001583	missense			ENSG00000175764	HGNC:18113	XM_088486	Approved	uc011lyl.2	NA		ENST00000321582.5	37	CCDS48012.1	.	.	.	.	.	.	.	.	.	.	T	18.53	3.645033	0.67358	.	.	ENSG00000175764	ENST00000321582;ENST00000373778;ENST00000373776	T;T	0.05513	3.43;3.43	5.51	5.51	0.81932	.	0.145674	0.47093	D	0.000254	T	0.08714	0.0216	L	0.42632	1.34	0.58432	D	0.999999	P;B	0.43633	0.813;0.274	B;B	0.44224	0.444;0.27	T	0.37478	-0.9704	10	0.23891	T	0.37	.	13.2854	0.60241	0.0:0.0:0.0:1.0	.	295;295	F8W6M1;Q8NHH1	.;TTL11_HUMAN	L	295;18;295	ENSP00000321346:Q295L;ENSP00000362881:Q295L	ENSP00000321346:Q295L	Q	-	2	0	TTLL11	123833902	1	0.71417	1	0.80357	0.998	0.95712	7.225	0.78051	2.226	0.72624	0.482	0.46254	CAG	TTLL11-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		87.585177	KEEP		-	90.802848	0.31	31	69	---	---	---	---	1	0.9999755	4	16	0	112	35	77	0	112	2	0	0	0	0	0	0	35	77	0	112	2	TP
PTEN	5728	broad.mit.edu	37	10	89692904	89692904	+	Nonsense_Mutation	SNP	C	C	T	rs121913292|rs121909224		GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	g.chr10:89692904C>T	ENST00000371953.3	+	5	1745	c.388C>T	c.(388-390)Cga>Tga	p.R130*		NM_000314.4	NP_000305.3	P60484	PTEN_HUMAN	phosphatase and tensin homolog	130	Phosphatase tensin-type.	NA	R -> G (loss of phosphatase activity towards Ins(1,3,4,5)P4 and PtdIns(3,4,5)P3).|R -> L (in CD and endometrial hyperplasia; loss of phosphatase activity towards Ins(1,3,4,5)P4; retains ability to bind phospholipid membranes).|R -> Q (in CD; loss of phosphatase activity towards Ins(1,3,4,5)P4; retains ability to bind phospholipid membranes).		activation of mitotic anaphase-promoting complex activity|apoptosis|canonical Wnt receptor signaling pathway|cell proliferation|central nervous system development|induction of apoptosis|inositol phosphate dephosphorylation|negative regulation of cell migration|negative regulation of cyclin-dependent protein kinase activity involved in G1/S|negative regulation of focal adhesion assembly|negative regulation of G1/S transition of mitotic cell cycle|negative regulation of protein kinase B signaling cascade|negative regulation of protein phosphorylation|nerve growth factor receptor signaling pathway|phosphatidylinositol dephosphorylation|phosphatidylinositol-mediated signaling|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of sequence-specific DNA binding transcription factor activity|protein stabilization|regulation of neuron projection development|T cell receptor signaling pathway	cytosol|internal side of plasma membrane|PML body	anaphase-promoting complex binding|enzyme binding|inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity|lipid binding|magnesium ion binding|PDZ domain binding|phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity|phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity|phosphatidylinositol-3-phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity	p.R130G(102)|p.R130*(63)|p.0?(37)|p.?(5)|p.R55fs*1(5)|p.K128_R130del(3)|p.Y27fs*1(2)|p.R130R(1)|p.A121_F145del(1)|p.R130fs*4(1)|p.G129fs*51(1)|p.F56fs*2(1)|p.G129fs*50(1)|p.K128fs*47(1)		NS(28)|autonomic_ganglia(2)|biliary_tract(6)|bone(5)|breast(92)|central_nervous_system(676)|cervix(26)|endometrium(1068)|eye(8)|haematopoietic_and_lymphoid_tissue(137)|kidney(24)|large_intestine(98)|liver(20)|lung(91)|meninges(2)|oesophagus(2)|ovary(82)|pancreas(6)|prostate(129)|salivary_gland(5)|skin(127)|soft_tissue(19)|stomach(30)|testis(1)|thyroid(29)|upper_aerodigestive_tract(29)|urinary_tract(12)|vulva(17)	2771		all_cancers(4;3.61e-31)|all_epithelial(4;3.96e-23)|Prostate(4;8.12e-23)|Breast(4;0.000111)|Melanoma(5;0.00146)|all_hematologic(4;0.00227)|Colorectal(252;0.00494)|all_neural(4;0.00513)|Acute lymphoblastic leukemia(4;0.0116)|Glioma(4;0.0274)|all_lung(38;0.132)	KIRC - Kidney renal clear cell carcinoma(1;0.214)	UCEC - Uterine corpus endometrioid carcinoma (6;0.000228)|all cancers(1;4.16e-84)|GBM - Glioblastoma multiforme(1;7.77e-49)|Epithelial(1;7.67e-41)|OV - Ovarian serous cystadenocarcinoma(1;6.22e-15)|BRCA - Breast invasive adenocarcinoma(1;1.1e-06)|Lung(2;3.18e-06)|Colorectal(12;4.88e-06)|LUSC - Lung squamous cell carcinoma(2;4.97e-06)|COAD - Colon adenocarcinoma(12;1.13e-05)|Kidney(1;0.000288)|KIRC - Kidney renal clear cell carcinoma(1;0.00037)|STAD - Stomach adenocarcinoma(243;0.218)		TGGAAAGGGACGAACTGGTGT	0.403	R130G(KMBC2_URINARY_TRACT)|R130G(OV56_OVARY)	31	"""D, Mis, N, F, S"""		"""glioma,  prostate, endometrial"""	"""harmartoma, glioma,  prostate, endometrial"""		NA	Proteus syndrome;Juvenile Polyposis;Hereditary Mixed Polyposis Syndrome type 1;Cowden syndrome;Bannayan-Riley-Ruvalcaba syndrome	HNSCC(9;0.0022)|TCGA GBM(2;<1E-08)|TSP Lung(26;0.18)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Rec	yes	"""Cowden Syndrome, Bannayan-Riley-Ruvalcaba syndrome"""	10	10q23.3	5728	phosphatase and tensin homolog gene		"""L, E, M, O"""	224	Substitution - Missense(102)|Substitution - Nonsense(63)|Whole gene deletion(37)|Deletion - Frameshift(10)|Unknown(5)|Deletion - In frame(4)|Insertion - Frameshift(2)|Substitution - coding silent(1)	endometrium(125)|central_nervous_system(37)|prostate(21)|ovary(10)|lung(9)|skin(6)|haematopoietic_and_lymphoid_tissue(5)|breast(3)|cervix(2)|large_intestine(2)|soft_tissue(2)|thyroid(1)|urinary_tract(1)	GRCh37	CM971273	PTEN	M	rs121909224				NA		141	131	134	NA		NA	NA	10		NA											NA				89692904		2203	4300	6503	SO:0001587	stop_gained	Familial Cancer Database	Incl.: Encephalocraniocutaneous Lipomatosis, ECCL, Proteus-like s.;incl.: Juvenile Polyposis of the Stomach;HMPS1, Colorectal Adenoma Carcinoma syndrome, CRAC, CRAC1;CS, Cowden disease, Multiple Hamartoma Syndrome, incl.: Lhermitte-Duclos; part of PTEN hamartoma tumour syndrome (PHTS) / PTEN-MATCHS, Cowden-like syndrome;subset of PTEN-Hamartoma Tumor Syndrome; incl.: Ruvalcaba-Myhre-Smith s.	ENSG00000171862	HGNC:9588	NM_000314	Approved	uc001kfb.3	NA	B2R904|O00633|O02679|Q6ICT7	ENST00000371953.3	37	CCDS31238.1	.	.	.	.	.	.	.	.	.	.	C	48	14.299622	0.99789	.	.	ENSG00000171862	ENST00000371953	.	.	.	5.22	5.22	0.72569	.	0.000000	0.85682	D	0.000000	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	.	.	.	-1.7685	18.7776	0.91918	0.0:1.0:0.0:0.0	.	.	.	.	X	130	.	.	R	+	1	2	PTEN	89682884	1	0.71417	1	0.80357	0.998	0.95712	5.527	0.67123	2.411	0.81874	0.655	0.94253	CGA	PTEN-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000049241.1	59.689302	KEEP		+	62.167321	0.3	21	49	---	---	---	---	1	1	11	103	0	188	22	56	0	188	2	1	1	86	185	0	280	22	56	0	188	2	TP
UBC	7316	broad.mit.edu	37	12	125397269	125397269	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	g.chr12:125397269G>A	ENST00000536769.1	-	1	2625	c.1049C>T	c.(1048-1050)gCc>gTc	p.A350V	UBC_ENST00000339647.5_Missense_Mutation_p.A350V|UBC_ENST00000538617.1_Intron|UBC_ENST00000536661.1_5'Flank|MIR5188_ENST00000583467.1_RNA|UBC_ENST00000546120.1_Missense_Mutation_p.A274V			P0CG48	UBC_HUMAN	ubiquitin C	350	Ubiquitin-like 5.	NA			activation of MAPK activity|anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process|anti-apoptosis|apoptosis|cellular membrane organization|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA repair|endosome transport|epidermal growth factor receptor signaling pathway|G1/S transition of mitotic cell cycle|I-kappaB kinase/NF-kappaB cascade|induction of apoptosis by extracellular signals|innate immune response|JNK cascade|M/G1 transition of mitotic cell cycle|mRNA metabolic process|MyD88-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway|negative regulation of epidermal growth factor receptor signaling pathway|negative regulation of type I interferon production|negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle|nerve growth factor receptor signaling pathway|positive regulation of I-kappaB kinase/NF-kappaB cascade|positive regulation of NF-kappaB transcription factor activity|positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle|S phase of mitotic cell cycle|stress-activated MAPK cascade|T cell receptor signaling pathway|Toll signaling pathway|toll-like receptor 1 signaling pathway|toll-like receptor 2 signaling pathway|toll-like receptor 3 signaling pathway|toll-like receptor 4 signaling pathway|viral reproduction	cytosol|endocytic vesicle membrane|endosome membrane|nucleoplasm|plasma membrane	protein binding			breast(3)|endometrium(4)|kidney(4)|large_intestine(2)|lung(13)|ovary(3)|prostate(4)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	36	all_neural(191;0.101)|Medulloblastoma(191;0.163)			OV - Ovarian serous cystadenocarcinoma(86;6.17e-05)|Epithelial(86;0.000207)|all cancers(50;0.00308)		CTGTTTTCCGGCAAAGATCAA	0.522		NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0											NA		191	172	179	NA		NA	NA	12		NA											NA				125397269		2203	4300	6503	SO:0001583	missense			ENSG00000150991	HGNC:12468	NM_021009	Approved	uc001ugs.4	NA	P02248|P02249|P02250|P62988|Q29120|Q6LBL4|Q6LDU5|Q8WYN8|Q91887|Q91888|Q9BWD6|Q9BX98|Q9UEF2|Q9UEG1|Q9UEK8|Q9UPK7	ENST00000536769.1	37	CCDS9260.1	.	.	.	.	.	.	.	.	.	.	G	17.55	3.416852	0.62511	.	.	ENSG00000150991	ENST00000536769;ENST00000535460;ENST00000541046;ENST00000339647;ENST00000546120	T;T;T	0.74842	-0.88;-0.88;-0.88	3.17	3.17	0.36434	Ubiquitin supergroup (1);Ubiquitin conserved site (1);Ubiquitin (2);	0.343088	0.19197	N	0.120281	T	0.82226	0.4991	M	0.74546	2.27	0.80722	D	1	P;P;P	0.46621	0.881;0.668;0.715	P;P;B	0.57244	0.816;0.63;0.365	D	0.84144	0.0419	10	0.72032	D	0.01	.	11.8774	0.52554	0.0:0.0:1.0:0.0	.	439;350;350	Q66K58;F5H7K6;P0CG48	.;.;UBC_HUMAN	V	350;350;274;350;274	ENSP00000441543:A350V;ENSP00000344818:A350V;ENSP00000438394:A274V	ENSP00000344818:A350V	A	-	2	0	UBC	123963222	1	0.71417	0.999	0.59377	0.98	0.70556	7.436	0.80404	1.615	0.50252	0.556	0.70494	GCC	UBC-007	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000400177.1	-61.719164	KEEP		-	8.012447	0.018657	5	263	---	---	---	---	1	1	18	7867	0	243	6	296	0	243	2	0	0	0	0	0	0	6	296	0	243	2	TP
TMEM107	84314	broad.mit.edu	37	17	8076720	8076720	+	3'UTR	SNP	T	T	C			GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	g.chr17:8076720T>C	ENST00000449985.2	-	0	1044				SNORD118_ENST00000363593.1_RNA			Q6UX40	TM107_HUMAN	transmembrane protein 107	NA		NA				integral to membrane				large_intestine(1)|lung(4)|ovary(1)	6						TAGCTATGTTTGTGGATATCT	0.398		NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0											NA		NA	NA	NA	NA		NA	NA	NA		NA											NA				NA		NA	NA	NA	SO:0001624	3_prime_UTR_variant				HGNC:28128	NM_032354	Approved	uc002gkh.4	NA	A0PJV7|Q6NSE3|Q6ZRX9|Q96T82	ENST00000449985.2	37													NA	NA	NA								NA	NA	NA												NA		NA															NA	NA												NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		TMEM107-004	PUTATIVE	basic|exp_conf	protein_coding	NA	protein_coding	OTTHUMT00000388841.1	60.769031	KEEP		-	66.023625	0.238095	20	64	---	---	---	---	1	0.9999997	30	59	0	95	24	73	0	95	2	0	0	0	0	0	0	24	73	0	95	2	TP
A1BG	1	broad.mit.edu	37	19	58858802	58858802	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	g.chr19:58858802C>T	ENST00000263100.3	-	7	1458	c.1397G>A	c.(1396-1398)gGc>gAc	p.G466D	A1BG-AS1_ENST00000594950.1_RNA|A1BG-AS1_ENST00000600379.1_RNA|CTD-2619J13.8_ENST00000599109.1_RNA|A1BG_ENST00000596924.1_5'UTR|A1BG-AS1_ENST00000600686.1_RNA|A1BG-AS1_ENST00000599728.1_RNA|A1BG-AS1_ENST00000593960.1_RNA|A1BG-AS1_ENST00000593374.1_RNA	NM_130786.3	NP_570602.2	P04217	A1BG_HUMAN	alpha-1-B glycoprotein	466	Ig-like V-type 5.	NA				extracellular region				NS(1)|cervix(1)|endometrium(1)|kidney(2)|large_intestine(1)|lung(7)|prostate(2)	15		all_cancers(17;3.04e-16)|all_epithelial(17;7.77e-12)|Lung NSC(17;3.25e-05)|Colorectal(82;5.46e-05)|all_lung(17;0.000129)|all_neural(62;0.0182)|Ovarian(87;0.0443)|Breast(46;0.0889)|Renal(17;0.157)		UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0269)		CCTGTAGTTGCCGGCGTGCTG	0.692		NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0											NA		18	22	20	NA		NA	NA	19		NA											NA				58858802		2196	4297	6493	SO:0001583	missense			ENSG00000121410	HGNC:5	NM_130786	Approved	uc002qsd.4	NA	A8K052|Q68CK0|Q8IYJ6|Q96P39	ENST00000263100.3	37	CCDS12976.1	.	.	.	.	.	.	.	.	.	.	C	21.9	4.218866	0.79464	.	.	ENSG00000121410	ENST00000263100	T	0.01572	4.76	3.68	3.68	0.42216	Immunoglobulin-like fold (1);	0.000000	0.43416	D	0.000564	T	0.12902	0.0313	M	0.92649	3.33	0.32621	N	0.523343	D	0.89917	1.0	D	0.97110	1.0	T	0.08576	-1.0715	10	0.87932	D	0	.	11.1708	0.48571	0.0:1.0:0.0:0.0	.	466	P04217	A1BG_HUMAN	D	466	ENSP00000263100:G466D	ENSP00000263100:G466D	G	-	2	0	A1BG	63550614	0	0.05858	0.981	0.43875	0.784	0.44337	-0.18	0.09754	2.101	0.63845	0.46	0.3903	GGC	A1BG-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000466930.1	57.520376	KEEP		-	57.646785	0.44186	19	24	---	---	---	---	1	1	154	207	0	36	20	28	0	36	2	0	0	0	0	0	0	20	28	0	36	2	TP
KIF16B	55614	broad.mit.edu	37	20	16337022	16337022	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	g.chr20:16337022C>T	ENST00000354981.2	-	23	3731	c.3574G>A	c.(3574-3576)Gtc>Atc	p.V1192I	KIF16B_ENST00000355755.3_Missense_Mutation_p.V1192I|KIF16B_ENST00000378003.2_Intron	NM_001199865.1|NM_024704.4	NP_001186794.1|NP_078980.3	Q96L93	KI16B_HUMAN	kinesin family member 16B	1192	PX.	NA			cell communication|early endosome to late endosome transport|endoderm development|epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|formation of primary germ layer|Golgi to endosome transport|microtubule-based movement|receptor catabolic process|regulation of receptor recycling	early endosome membrane|microtubule	ATP binding|phosphatidylinositol-3,4,5-trisphosphate binding|phosphatidylinositol-3,4-bisphosphate binding|phosphatidylinositol-3,5-bisphosphate binding|phosphatidylinositol-3-phosphate binding|plus-end-directed microtubule motor activity			NS(2)|breast(1)|central_nervous_system(1)|cervix(1)|endometrium(3)|kidney(6)|large_intestine(15)|lung(24)|ovary(1)|prostate(15)|skin(3)|upper_aerodigestive_tract(2)	74						CCGCAGAGGACGTAGCGTGGG	0.498		NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0											NA		134	105	115	NA		NA	NA	20		NA											NA				16337022		2203	4300	6503	SO:0001583	missense			ENSG00000089177	HGNC:15869	NM_017683	Approved	uc010gci.2	NA	A6NKJ9|A7E2A8|B1AKG3|B1AKT7|C9JDN5|C9JI52|C9JSM8|C9JWJ7|Q2TBF5|Q5HYC0|Q5HYK1|Q5JWW3|Q5TFK5|Q86VL9|Q86YS5|Q8IYU0|Q9BQJ8|Q9BQM0|Q9BQM1|Q9BQM5|Q9H5U0|Q9HCI2|Q9NXN9	ENST00000354981.2	37	CCDS13122.1	.	.	.	.	.	.	.	.	.	.	C	15.31	2.794209	0.50102	.	.	ENSG00000089177	ENST00000354981;ENST00000355755;ENST00000377997	T;T	0.28895	1.59;1.59	5.6	4.65	0.58169	Phox homologous domain (4);	.	.	.	.	T	0.18964	0.0455	N	0.11560	0.145	0.80722	D	1	B	0.17268	0.021	B	0.15052	0.012	T	0.04723	-1.0931	9	0.51188	T	0.08	.	14.27	0.66147	0.0:0.9284:0.0:0.0715	.	1192	Q96L93	KI16B_HUMAN	I	1192;1192;1036	ENSP00000347076:V1192I;ENSP00000347995:V1192I	ENSP00000347076:V1192I	V	-	1	0	KIF16B	16285022	1	0.71417	0.997	0.53966	0.996	0.88848	3.479	0.53165	2.795	0.96236	0.643	0.83706	GTC	KIF16B-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000078104.2	8.433679	KEEP		-	14.532227	0.130435	6	40	---	---	---	---	1	0.6113192	3	21	1	75	6	43	1	75	3	0	0	0	0	0	0	6	43	1	75	2	TP
NRIP1	8204	broad.mit.edu	37	21	16340303	16340303	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	g.chr21:16340303G>A	ENST00000400202.1	-	3	923	c.211C>T	c.(211-213)Cat>Tat	p.H71Y	NRIP1_ENST00000318948.4_Missense_Mutation_p.H71Y|NRIP1_ENST00000400199.1_Missense_Mutation_p.H71Y			P48552	NRIP1_HUMAN	nuclear receptor interacting protein 1	71		NA			androgen receptor signaling pathway|negative regulation of transcription from RNA polymerase II promoter|positive regulation of transcription from RNA polymerase II promoter|transcription, DNA-dependent		androgen receptor binding|estrogen receptor binding|glucocorticoid receptor binding|transcription coactivator activity|transcription corepressor activity			cervix(3)|haematopoietic_and_lymphoid_tissue(2)|kidney(5)|large_intestine(6)|lung(13)|prostate(4)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(4)	39				Epithelial(23;1.19e-05)|all cancers(11;4.64e-05)|COAD - Colon adenocarcinoma(22;0.000232)|Colorectal(24;0.0006)|OV - Ovarian serous cystadenocarcinoma(11;0.00418)|Lung(58;0.199)|LUSC - Lung squamous cell carcinoma(23;0.24)		TGATATGTATGTGTATTGAGA	0.458		NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0											NA		61	54	57	NA		NA	NA	21		NA											NA				16340303		2203	4300	6503	SO:0001583	missense			ENSG00000180530	HGNC:8001	NM_003489	Approved	uc002yjx.2	NA	Q8IWE8	ENST00000400202.1	37	CCDS13568.1	.	.	.	.	.	.	.	.	.	.	G	8.369	0.834973	0.1682	.	.	ENSG00000180530	ENST00000400199;ENST00000400202;ENST00000318948	T;T;T	0.07908	3.15;3.15;3.15	5.58	2.46	0.2998	.	0.694414	0.14632	N	0.307744	T	0.04861	0.0131	N	0.19112	0.55	0.24589	N	0.993835	B	0.02656	0.0	B	0.04013	0.001	T	0.44467	-0.9326	10	0.13853	T	0.58	-3.9649	7.5484	0.27781	0.0862:0.0:0.3754:0.5384	.	71	P48552	NRIP1_HUMAN	Y	71	ENSP00000383060:H71Y;ENSP00000383063:H71Y;ENSP00000327213:H71Y	ENSP00000327213:H71Y	H	-	1	0	NRIP1	15262174	0.593	0.2684	0.921	0.36526	0.805	0.45488	1.785	0.38684	0.706	0.31912	-0.188	0.12872	CAT	NRIP1-002	KNOWN	alternative_5_UTR|not_organism_supported|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000157926.1	13.066527	KEEP		-	13.866773	0.277778	5	13	---	---	---	---	1	0.9387097	4	13	0	47	5	13	0	47	2	0	0	0	0	0	0	5	13	0	47	2	TP
CBR1	873	broad.mit.edu	37	21	37445093	37445093	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5411-Tumor-SM-1Y493	GBM-TCGA-06-5411-Normal-SM-1Y48X	g.chr21:37445093G>T	ENST00000290349.6	+	3	922	c.747G>T	c.(745-747)gaG>gaT	p.E249D	AP000688.14_ENST00000535199.1_RNA|SETD4_ENST00000399201.1_Intron|CBR1_ENST00000530908.1_3'UTR	NM_001757.2	NP_001748.1	P16152	CBR1_HUMAN	carbonyl reductase 1	249		NA			drug metabolic process|vitamin K metabolic process	cytoplasm	15-hydroxyprostaglandin dehydrogenase (NADP+) activity|carbonyl reductase (NADPH) activity|prostaglandin-E2 9-reductase activity|protein binding			endometrium(2)|kidney(3)	5					Acetohexamide(DB00414)|Lubiprostone(DB01046)	AAGGTGCAGAGACCCCTGTGT	0.572		NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0											NA		68	68	68	NA		NA	NA	21		NA											NA				37445093		2203	4300	6503	SO:0001583	missense			ENSG00000159228	HGNC:1548		Approved	uc002yvb.1	NA	B2RBZ7|Q3LHW8	ENST00000290349.6	37	CCDS13641.1	.	.	.	.	.	.	.	.	.	.	G	11.23	1.577331	0.2818	.	.	ENSG00000159228	ENST00000290349	T	0.09350	2.99	5.85	2.45	0.29901	NAD(P)-binding domain (1);	0.156920	0.56097	D	0.000024	T	0.07007	0.0178	N	0.20483	0.58	0.80722	D	1	B	0.02656	0.0	B	0.04013	0.001	T	0.29427	-1.0012	10	0.25751	T	0.34	-24.3451	11.7406	0.5179	0.2384:0.0:0.7616:0.0	.	249	P16152	CBR1_HUMAN	D	249	ENSP00000290349:E249D	ENSP00000290349:E249D	E	+	3	2	CBR1	36366963	1	0.71417	1	0.80357	0.969	0.65631	2.679	0.46909	0.724	0.32296	-0.136	0.14681	GAG	CBR1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000194633.2	49.832617	KEEP		+	54.259455	0.256098	21	61	---	---	---	---	1	1	358	1226	0	73	25	71	0	73	2	0	0	0	0	0	0	25	71	0	73	2	TP
